Posts Tagged ‘CRO’

  Over the past few months, the life sciences practice has produced several free resources related to the 21 CFR Part 11 regulation that governs electronic records and electronic signatures. To make it easy for our industry colleagues to find those resources, we decided to create a single blog post that links to all of […]

  One of the most common questions we hear from clients is “What file formats can Google Search Appliance (GSA) index?” Since so many people are curious, we decided to share the answer with you in our blog. It goes a little something like this: The number of file formats GSA can index is incredible. […]

<   The work we’re doing for life sciences and healthcare companies continues to pay off. And, Oracle thinks so, too. We recently received an award from Oracle’s Health Sciences Global Business Unit for the work we’re doing with their clinical and pharmacovigilance applications. 

One of my LinkedIn contacts shared the video Risk-Based Monitoring vs Remote Monitoring Finally Explained, in which Dan Sfera of www.theclinicaltrialsguru.com explains both concepts in layman’s terms. In essence, the idea of Risk-Based Monitoring (RBM) is to leverage the data in existing IT systems to spot, rectify, and prevent issues relating to the execution of […]

  Several months ago we delivered a webinar on 21 CFR Part 11, based on a recent blog series. During the Q&A session at the end, someone asked the following question: Regarding “the organization” that needs to inform the FDA of the intended use of electronic signatures, in a CRO/Sponsor relationship, who is responsible: the […]

  When you think of a pharmaceutical companies, you think drugs. You think of them as a business – drugs being developed, sold, and consumed. Not often do you think of them as do-gooders. 

  Most of us “regular people” refer to pharmaceutical products by their trade name, but that’s not the case among life sciences professionals in research and development departments. In fact, during a product’s lifecycle, chances are it has been referred to by at least four names: a chemical compound, a company code, a generic name, […]

  While 6 medical device companies and 11 pharmaceutical organizations made the cut for this year’s Fortune 500 list, Quintiles (#476) was the only contract research organization (CRO) to make an appearance. With over $4 billion in revenue in 2014, this is Quintiles’ second year on the list. To see which pharma and biotech companies […]

Photo Credit: Maglara / Shutterstock.com My colleague, Beth Martin, wrote a great blog post today about the benefits of using Google Search for Work. What is Google Search for Work, you ask? Think of it as using Google to search the Internet, except that you search your company’s systems instead. Take a look at the infographic below, which […]

  Now that July is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in June – they’re ranked in order of popularity, with number one being the most viewed piece. 

  On Thursday, April 23, 2015, we delivered a webinar on 21 CFR Part 11, based on a recent blog series. During the Q&A session at the end, someone asked the following question: In one of the initial slides, you mentioned that documents attached to emails do not fall under 21 CFR Part 11. Could […]

  What do you do when the largest contract research organization (CRO) in the world agrees to appear in a video promoting several products? You watch, of course! Quintiles recently recorded a video that features the company’s president of clinical development discussing their use of Oracle Health Sciences solutions, such as Siebel Clinical Trial Management […]